shouldiuse.io

Categories

VERDICT

Should I use QuPath?

QuPath is cross-platform, user-friendly open source software for digital pathology and whole slide image analysis, written using JavaFX. QuPath has also been designed to be developer-friendly, and combines an extensible design with powerful scripting tools. - qupath.github.io

Worth it. Essential for research labs analyzing whole-slide images — free, extensible, and competitive with paid platforms. Not for clinical diagnosis or anyone needing vendor support and validation.

Confidence

Medium. Based on 16 public sources: peer-reviewed papers, forums, Reddit, and official docs.

Ratings

  • Value for money
  • Ease of use
  • Feature depth
  • Support quality
  • Security posture

Pricing

$0

Open source

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
Free tierYes

Best for

  • Cancer research labs quantifying whole-slide images
  • Core imaging facilities on tight budgets
  • Multiplex immunofluorescence analysis
  • Bioimage analysts comfortable with scripting

Not for

  • Clinical diagnosis — it is a research tool, not validated software (Guess:)
  • Anyone needing vendor support, SLAs, or training contracts
  • Weak laptops — whole-slide images choke underpowered hardware
  • Teams wanting turnkey regulated pipelines; buy HALO or Visiopharm instead

Gotchas - check before you buy

medium

Budget for a workstation — RAM, SSD, GPU — not a laptop

medium

No paid support path; you rely on forum volunteers and docs

medium

Validate pipelines across versions; reproducibility complaints exist

low

Roadmap follows academic grants (Wellcome, CZI), not paying customers

Pros and cons

Pros

  • Completely free and open source, including all analysis features
  • Free alternative to paid platforms HALO and Visiopharm
  • 130K+ downloads signal strong adoption in pathology research
  • Extensible design with powerful scripting tools
  • Backed by Wellcome and Chan Zuckerberg Initiative grants

Cons

  • Whole-slide images demand high-end workstation hardware
  • Support is community forums; no vendor SLA
  • Reported performance issues with batch pixel classification
  • Users report inconsistent results despite identical imaging

Sources & method

Analyzed 10/03/2026 - 16 sources - No known vulnerabilities found in the sources reviewed.

official x6review x7security x2news x1

Key stats

  • Value for money: 5/5

    Rating

  • $0

    Starting price

  • 16

    Sources

  • Analyzed

  • Value for money: 5/5. Free, yet competes with licensed platforms
  • Ease of use: 4/5. User-friendly core; scripting for advanced work
  • Feature depth: 5/5. Scripting, extensions, whole-slide and multiplex analysis
  • Support quality: 3/5. Active community forums; no vendor support
  • Security posture: 4/5. No public CVEs found; Linux Foundation-tracked
  • $0 Price Free and open source
  • 130K+ Downloads Reported all-time
  • 2017 First published Bankhead et al., Scientific Reports
  • Wellcome + CZI Funding Nonprofit grants, no VC

Pricing

Open source

$0

  • Full desktop application
  • Scripting and extensions
  • Community support only

Security

No known vulnerabilities found in the sources reviewed.

What users say

Researchers broadly praise QuPath as a powerful free tool, with occasional gripes about hardware demands and reproducibility.

“100% QuPath is amazing.”
Reddit, r/labrats
“QuPath/napari are useful”
Reddit, r/bioinformatics

Companies that use it

  • University of Edinburgh
  • Harvard Medical School
  • U.S. Department of Veterans Affairs13
  • University of Copenhagen
Full analysis

Based on 16 public sources: peer-reviewed papers, forums, Reddit, and official docs.

Free open-source digital pathology analysis that rivals paid tools — bring a workstation, not a laptop.

Methodology

Based on 16 public sources: peer-reviewed papers, forums, Reddit, and official docs.

Sources

  1. QuPath official sitequpath.github.io
    official
  2. QuPath: Open source software for digital pathology image analysis (2017)pmc.ncbi.nlm.nih.gov
    official
  3. The global impact of an open source digital pathology system (2021)pmc.ncbi.nlm.nih.gov
    review
  4. Comparison of QuPath and HALO platforms (bioRxiv 2025)biorxiv.org
    review
  5. Solving Unpopular Problems: The QuPath Storythepathologist.com
    news
  6. Digital Pathology Place podcast with Pete Bankheaddigitalpathologyplace.com
    review
  7. Workstation hardware discussion (image.sc forum)forum.image.sc
    review
  8. Batch processing performance issue (GitHub)github.com
    review
  9. Inconsistent analysis results thread (image.sc forum)forum.image.sc
    review
  10. Getting help — QuPath docsqupath.readthedocs.io
    official
  11. Wellcome funded grantwellcome.org
    official
  12. Chan Zuckerberg Initiative EOSS proposalchanzuckerberg.com
    official
  13. VA Technical Reference Model listingoit.va.gov
    official
  14. GitHub security pagegithub.com
    security
  15. LFX Insights security overviewinsights.linuxfoundation.org
    security
  16. Reddit r/labrats praise threadreddit.com
    review

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.